Martin McMahon

24PUBLICATIONS
83CO-AUTHORS
Molecular targetsPredictive and prognostic markersToxicology (incl. clinical toxicology)Psychopharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.

|Apr 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

|Dec 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

Mona Foth, Wontak Kim, Kayla T O'Toole

|Sep 05, 2025
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.

Allie Grossmann, Junhua Wang, Yinshen Wee

|Jul 16, 2025
Characterization of the BRAF interactome identifies BRAF V600E TP53 interaction in melanoma.

Kayla T O'Toole, Adamaris Martinez, Brandon Murphy

|Aug 30, 2024
Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer.

Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram

Pageof 4

Frequent Collaborators

8 joint publications

Mona Foth

5 joint publications

Sheri L Holmen

4 joint publications

Gennie Parkman

4 joint publications

Conan Kinsey